With the commitment of being your best drug discovery partner, Creative Biolabs is capable of providing our clients with different kinds of customized laboratory-based marker development services during the process of psychotropic drug discovery. Equipped with a team of professional scientists, we have won a good reputation among our worldwide customers for accomplishing numerous challenging projects in this field. In our company, our scientists specialized in marker development studies will work with you to develop the most appropriate strategy that will offer reproducible data for your research.
Introduction to Biomarkers
In the pharmaceutical industry, biomarkers have been considered as a key parameter for evaluating the occurrence, progression, as well as severity of specific diseases. Nowadays, a wide variety of biomarker types, such as cell biomarkers, molecular biomarkers, genetic biomarkers, and diagnostic biomarkers, have been used in many pre-clinical studies and clinical diagnoses for psychiatric disorders. For example, genetic biomarkers are a group of substances that consist of various DNA sequences on different chromosomes. Pilot studies have indicated that genetic biomarkers play an important role in linking psychiatric disorders with pathogenic genes. Moreover, recent reports have revealed that biomarkers can also reflect changes in disease-associated protein expression levels or the susceptibility of a disease to a particular treatment. As a result, many attempts have been made to design more effective markers for preventing or treating psychiatric disorders. Among them, laboratory-based markers have been generated as a powerful tool for the development of psychotropic drugs.
Laboratory-based Marker Development Services in Psychiatric Diseases
Currently, biomarkers development, especially for laboratory-based biomarkers development, has been regarded as diagnostics or an essential part of drug discovery. Furthermore, once an effective laboratory-based marker has been confirmed, it can be used for evaluating disease risk and monitoring of disease progression in clinical trials. As a consequence, Creative Biolabs has developed a laboratory-based marker development platform for helping identify potential markers in the psychotropic drug discovery process.
In our company, we can offer a comprehensive solution for laboratory-based marker studies, including but not limited to, biomarker screening, biomarker validation, safety evaluation, as well as the clinical diagnosis. Up to now, various types of laboratory-based markers, such as enzymes, proteins, metabolites, and catecholamines, have been identified in patients with psychiatric disorders, like post-traumatic stress disorder (PTSD), major depressive disorder (MDD), and schizophrenia, to observe different stages of disease state and to test the clinical response of new psychiatric drugs. Besides, given the complexity of the pathogenesis of psychiatric disorders, it is unrealistic to use a specific laboratory-based marker to diagnose and treat multiple psychiatric disorders. Therefore, many studies have been designed by our scientists to focus on identifying a series of biomarkers that are associated with a specific psychiatric disorder.
Why Choose Us?
Creative Biolabs is a leader in the field of psychotropic drug discovery and has focused on laboratory-based marker development services for years. We have experienced experts and advanced platforms that can provide excellent services.
-
Fully integrated laboratory-based marker development platform
-
Cost-effective and efficient solutions
-
Fast turnaround time
-
Authoritative data reports
With years of operational experience, Creative Biolabs offers the best services for psychotropic drug development projects. Now, we have developed efficient protocols for laboratory-based biomarker development services to meet any requirements of our clients. If you have any special needs in our biomarker development services or be interested in learning more about our company, please feel free to contact us for more details.
For Research Use Only.
